Anika Therapeutics, Inc. (ANIK)
21.57
+0.46
(+2.18%)
USD |
NASDAQ |
Sep 02, 16:00
21.57
0.00 (0.00%)
After-Hours: 19:03
Anika Therapeutics Cash from Operations (Annual) : 11.19M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 11.19M |
| December 31, 2024 | 5.403M |
| December 31, 2023 | -1.788M |
| December 31, 2022 | 4.409M |
| December 31, 2021 | 8.397M |
| December 31, 2020 | 13.06M |
| December 31, 2019 | 37.00M |
| December 31, 2018 | 34.92M |
| December 31, 2017 | 40.81M |
| December 31, 2016 | 23.80M |
| December 31, 2015 | 39.06M |
| December 31, 2014 | 39.98M |
| December 31, 2013 | 25.16M |
| December 31, 2012 | 10.55M |
| December 31, 2011 | 10.17M |
| December 31, 2010 | 7.854M |
| Date | Value |
|---|---|
| December 31, 2009 | 3.095M |
| December 31, 2008 | 3.407M |
| December 31, 2007 | 4.493M |
| December 31, 2006 | 2.001M |
| December 31, 2005 | 6.452M |
| December 31, 2004 | 23.82M |
| December 31, 2003 | 2.012M |
| December 31, 2002 | 0.332M |
| December 31, 2001 | -4.314M |
| December 31, 2000 | -1.883M |
| December 31, 1999 | 0.8121M |
| December 31, 1998 | 3.353M |
| December 31, 1997 | 2.634M |
| August 31, 1996 | -1.634M |
| August 31, 1995 | -1.728M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Perspective Therapeutics, Inc. | -82.48M |
| MiMedx Group, Inc. | 74.00M |
| ABVC BioPharma, Inc. | -2.986M |
| Enovis Corp. | 217.29M |
| Edwards Lifesciences Corp. | 1.595B |